Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) in Elche, have identified a strategy to slow their progression, which could improve the response to current treatments.
Great Britain approves subcutaneous Tecentriq weeks ahead of expected US decision
Patients in Great Britain who take IV Tecentriq now have a quicker option. The country’s regulatory authority has approved a subcutaneous version of atezolizumab, better
August 30, 2023